>>> US Gapping up

Gapping up 
In reaction to strong earnings/guidance:
  • ACHN +20.2%, OTIV +20.2%, OREX +18%, NOG +15%, ENG +13.8%, SSTI +13.5%, VCEL +13.3%, NVAX +11.2%, TROX +11.2%, TPIC +10.8%, ACAD +10.4%, HTGM +8.7%, PXLW +8.7%, EVRI +8.5%, GSVC +8.5%, NVTR +8.1%, RRGB +7.9%, GPOR +7.8%, REXX +7.7%, ALDR +7.6%, ALRM +7.6%, YUME +7.1%, NVO +6.7%, SN +6.3%, SSNI +6.2%, ATHM +6.2%, WWW +6.2%, WATT +5.5%, ARLZ +5.3%, KAR +4.8%, OMER +4.7%, NSTG +4.6%, (NanoString Technologies and Lam Research (LRCX) announce strategic collaboration to develop NanoString's proprietary Hyb & Seq next generation sequencing platform), TPVG +4.3%, SSYS +4.3%, HTZ +3.6%, CLDX +3.5%, JNCE +3.4%, PRSC +3.3%, ARRY +3.2%, GNCA +2.9%, ECYT +2.8%, PUMP +2.6%, ARDX +2.6%, HALO +2.5%, IOSP +2.5%, ABCO +2.4%, NKTR +2.3%, DRRX +2.3%, DXC +2.3%, CARS +2.3%, ENPH +2.2%, RELY +2%, DHT +2%, TGTX +2%, PRMW +1.9%, ARA +1.9%, ETP +1.9%, PTCT +1.9%, MGIC +1.9%, AIMT +1.8%, AVT +1.8%, XEC +1.6%, PLPM +1.6%, WEN +1.6%, PLX +1.5%, ERI +1.3%, BUFF +1.3%, (approves $50 mln share repurchase program), CEMP +1.3%, BCEI +1.2%, IPXL +1%, MDCO +1%, .

M&A news:

  • STS +35.4% ( Wabash National Corporation (WNC) to acquire Supreme Industries in cash tender offer for $21 per share -- represents equity value of $364 mln and enterprise value of $342 mln; to be accretive in first full calendar year after close)
  • TEVA +1.7% (reports the company may look to accelerate potential asset sales)
  • PLPM +1.6% (to explore and evaluate potential strategic alternatives)
  • CFMS +1.1% (acquires the machining and polishing assets of Broad Peak Manufacturing for approximately $6.5 million)

Other news:

  • XTNT +28.4% (FDA has cleared product line extensions for the Calix-C family of cervical interbody cages)
  • RXII +12.1% (enters into common stock purchase agreement with Lincoln Park Capital)
  • MBRX +8.7% (comments on 'several recent FDA approvals for new drugs for the treatment of acute myeloid leukemia')
  • ANTH +6.8% (granted orphan drug designation by the FDA for blisibimod for the treatment of patients with immunoglobulin A nephropathy)
  • YNDX +3.9% (Yandex N.V. and Sberbank (SBRCY) form JV; Sberbank to invest $500 mln into Yandex.Market)

Analyst comments:

  • RIG +1.2% (upgraded to Neutral from Sell at Goldman)
  • VOD +0.6% (upgraded to Buy from Neutral at BofA/Merrill)